Karlsson, E., Pérez-Tenorio, G., Amin, R., Bostner, J., Skoog, L., Fornander, T., . . . Stål, O. (2013). The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: A retrospective study including patients from the randomised Stockholm tamoxifen trials. BioMed Central.
Citação norma ChicagoKarlsson, Elin, et al. The MTOR Effectors 4EBP1 and S6K2 Are Frequently Coexpressed, and Associated With a Poor Prognosis and Endocrine Resistance in Breast Cancer: A Retrospective Study Including Patients From the Randomised Stockholm Tamoxifen Trials. BioMed Central, 2013.
Citação norma MLAKarlsson, Elin, et al. The MTOR Effectors 4EBP1 and S6K2 Are Frequently Coexpressed, and Associated With a Poor Prognosis and Endocrine Resistance in Breast Cancer: A Retrospective Study Including Patients From the Randomised Stockholm Tamoxifen Trials. BioMed Central, 2013.